Abstract:T cell receptors (TCR) are a collection of several proteins located in the outer membrane of the T cell. Mature T cell has definitive TCR genes,which may be used as a clonal marker. To investigate whether TCR gene analysis may be useful for diagnosis of myasthenia gravis (MG) with thymoma, we used the cDNA of the β－ subunit of the TCR served as probes to analyze the structure of the TCR β gene and to determine the extent of diversity between MG with thymoma and MG without thymoma. Eighteen patients were clinically diagnosed generalized MG, eight of them had thymoma. Peripheral blood lymphocytes (PBL) were obtained at or shortly before thymectomy (except one, 2 years after thymectomy). When DNA was digested with EcoRI and hybridized with the 32P labeled probes, two germline bands of 10.5kb and 4.0 kb appeared in DNAs from all 18 patients. The 10.5 kb band contains the C β 1 region and the 4.0kb fragment the C β 2 region, respectively. The 4.0 kb band is usually reduced as compared with the 10.5kb band. This can be explained by the preferential rearrangement of the C β 2 gene in T cell with MG. We were able to demonstrate a rearranged band of 9kb in EcoRI－ digested DNAs of four patients. All the four patients had been found to have thymoma , of which 2 were lymphocyte and 2 mixed type. But rearranged bands could not be detected in the DNAs of another four patients with thymoma, of which 2 were epithelial and 2 mixed type. When DNA was digested with HindIII and BglII, germline bands appeared in DNAs from all patients. No rearranged bands could be observed . Single rearranged bands were detected in four patients with thymoma, this showed that specific TCR gene rearrangement may be related to certain types of thymoma . Detection of TCR gene rearrangement might be helpful to the early diagnosis of MG with thymoma . But we were unable to find gene rearrangement in another four thymoma (2 were epithelial and 2 mixed type). There are three possible explanations for the results. First, thymoma has heterogeneity. Second, TCR gene rearrangement only reflects the clonal origin of the T cell tumor. Third, in one patient, peripheral blood lymphocytes were obtained two years after thymectomy, neoplastic T cells maybe disappear. Thus, our results suggested that TCR gene rearrangement in patients with MG may be helpful for diagnosing certain type of thymoma.

Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis

Immunohistochemical Changes on Dendritic Cells in Microenvironment of Thymus in Patients with Myasthenia Gravis

Increased Frequency of Thymic T Follicular Helper Cells in Myasthenia Gravis Patients with Thymoma

Stereotypic T cell receptor clonotypes in the thymus and peripheral blood of Myasthenia gravis patients

Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis-associated thymoma

Non-neuronal cholinergic activity is potentiated in myasthenia gravis

Conventional dendritic cells are more activated in the hyperplastic Thymus of myasthenia gravis patients

Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis thymoma

Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis

Increase of circulating CD4 +CD25 + T cells in myasthenia gravis patients with stability and thymectomy

Augmentation Of Circulating Follicular Helper T Cells And Their Impact On Autoreactive B Cells In Myasthenia Gravis

Study of T Cell Receptor Gene Rearrangements in Patients with Myasthenia Gravis

Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma

The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis

Distribution of multi-level B cell subsets in thymoma and thymoma-associated myasthenia gravis

Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4+CD8+ thymocytes

Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features

Peripheral Immune Landscape for Hypercytokinemia in Myasthenic Crisis Utilizing Single-Cell Transcriptomics.

Advances in the Pathogenesis of Thymus and Myasthenia Gravis

Macrophage migration inhibitory factor: A noval biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse

Significance of B10 cell in patients with thymoma complicated with myasthenia gravis